P3 Health Partners (PIII)
(Delayed Data from NSDQ)
$0.45 USD
-0.03 (-7.02%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.45 0.00 (0.85%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
PIII 0.45 -0.03(-7.02%)
Will PIII be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PIII based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PIII
3 Medical Info Systems Stocks to Buy as Industry Rebounds
Zacks Industry Outlook Highlights P3 Health Partners, Talkspace and Augmedix
PIII: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Medical Info Systems Stocks to Buy as Industry Trends Improve
Here's Why P3 Health Partners Inc. (PIII) is Poised for a Turnaround After Losing -28.57% in 4 Weeks
Here Is Why Bargain Hunters Would Love Fast-paced Mover P3 Health Partners Inc. (PIII)
Other News for PIII
12 Health Care Stocks Moving In Monday's After-Market Session
P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conference
P3 Health Partners just downgraded at BTIG
Analysts Offer Insights on Healthcare Companies: Forian (FORA), Achieve Life Sciences (ACHV) and P3 Health Partners (PIII)
P3 Health Partners just downgraded at BTIG, here's why